Australia markets closed

Evoke Pharma Inc (EV00.BE)

Berlin - Berlin Delayed price. Currency in EUR
Add to watchlist
1.4600+0.0100 (+0.69%)
At close: 09:45PM CET
Full screen
Previous close1.4500
Open1.4400
Bid1.4000 x N/A
Ask1.5200 x N/A
Day's range1.4400 - 1.4600
52-week range1.3900 - 11.6100
VolumeN/A
Avg. volume0
Market capN/A
Beta (5Y monthly)N/A
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings date09 Nov 2022
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Simply Wall St.

    Evoke Pharma Third Quarter 2022 Earnings: Beats Expectations

    Evoke Pharma ( NASDAQ:EVOK ) Third Quarter 2022 Results Key Financial Results Revenue: US$832.1k (down 11% from 3Q...

  • GlobeNewswire

    Evoke Pharma Reports Record Third Quarter 2022 Financial Results

    80% increase in GIMOTI® net revenue over Q2 202256% increase of GIMOTI prescription fills in Q3 compared to Q213% increase of new prescribers of GIMOTI over Q2 SOLANA BEACH, Calif., Nov. 09, 2022 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI) diseases, today announced its financial results for the third quarter ended September 30, 2022 and recent corporate developments. “Evoke delivered record fi

  • GlobeNewswire

    Evoke Pharma to Report Third Quarter Results on November 9, 2022

    SOLANA BEACH, Calif., Nov. 02, 2022 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today announced that the Company is scheduled to release its third quarter on Wednesday, November 9, 2022, after the market closes. Management will host a conference call on Wednesday, November 9, 2022, at 4:30 p.m. ET to discuss the results. The dial-in numbers for the conference call are (800) 245-3047 and (203)